Michael Shaw
Background and experience
Michael is ZS’s global head of risk and compliance, leveraging more than 25 years in life sciences to help clients manage risk, enable innovation and improve business performance and patient outcomes. For more than 10 years, Michael was the vice president of ethics and compliance officer at GlaxoSmithKline (GSK) and a member of U.S. and global commercial leadership teams. Michael led and delivered competitive practices that drove measurable positive impact to GSK’s reputation and risk mitigation, while enabling strong business performance, effective collaboration between commercial and medical teams, increased employee engagement and improved patient health outcomes.
Michael continues to be an invited speaker at many industry conferences and events and has served in leadership roles for the Pharmaceutical Research and Manufacturers of America and the Pharmaceutical Compliance Forum.
Prior to GSK, Michael served in various leadership roles at Novartis, where he designed, implemented and led the first global ethics and compliance program for its oncology enterprise after he successfully developed the ethics and compliance program for the U.S. pharmaceuticals business. Michael was also a director in PwC’s global pharmaceutical and health sciences practice where he advised more than 24 life sciences companies on how to manage risk, be competitive and develop an ethical corporate culture.
Michael is also a former senior counsel with the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services, where he helped develop strategic initiatives for the OIG and practical guidance for the healthcare industry. He was previously an adjunct professor at Seton Hall Law School teaching healthcare fraud and abuse law.
Education
B.S., State University of New York at Albany
J.D., New York Law School